NCT06729957 (ABC-SUD) is a NA clinical trial of Care Navigation in Drug Use Disorders, sponsored by Kaiser Permanente.

Who is sponsoring NCT06729957?

NCT06729957 is sponsored by Kaiser Permanente.

What drugs are being tested in NCT06729957?

Interventions in NCT06729957: Care Navigation.

What condition does NCT06729957 study?

NCT06729957 studies Drug Use Disorders, Alcohol-Related Disorders, Substance Use Disorder (SUD).

Is NCT06729957 still recruiting?

NCT06729957 is currently active, enrolled. Last updated 27 February 2026.

Last reviewed 2026-02-27 · How we verify

NCT06729957: ABC-SUD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addressing Barriers to Care for Substance Use Disorder Trial

Active, enrolled NA Last updated 27 February 2026

What this trial tests

NA trial testing Care Navigation in Drug Use Disorders in 360 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

16 December 2024

Primary endpoint
21 August 2026

21 August 2026

Quick facts

Lead sponsor	Kaiser Permanente
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	health services research
Enrollment	360
Start date	16 December 2024
Primary completion	21 August 2026
Estimated completion	21 August 2026
Sites	1 location across United States

Drugs / interventions tested

Care Navigation

Conditions studied

Drug Use Disorders — all drugs for Drug Use Disorders →
Alcohol-Related Disorders — all drugs for Alcohol-Related Disorders →
Substance Use Disorder (SUD) — all drugs for Substance Use Disorder (SUD) →

Sponsor

Kaiser Permanente — full company profile →

Who can join

18 and older, any sex, with Drug Use Disorders or Alcohol-Related Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Addressing Barriers to Care for Substance Use Disorder Trial (ABC-SUD) is a cluster-randomized crossover trial, with clinicians (care coordinators) as the unit of randomization. This study will be conducted in a mental health access center within the Washington region of Kaiser Permanente. As part of usual care, patients contact the mental health access center and speak to a care coordinator to obtain an appointment with or contact information for potential venues to obtain treatment for substance use disorder. The experimental intervention, Care Navigation, will be evaluated for its potential to increase engagement in substance use disorder treatment among patients who contact the mental health access center. Care Navigation will be delivered by study care navigators, who are distinct from the health system's care coordinators.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Design of a cluster-randomized, hybrid type 1 effectiveness-implementation trial of a care navigation intervention to increase substance use disorder treatment engagement: study protocol.
Matson TE, Navarro MA, Idu A, Bobb JF, et al · · 2025 · PMID 41035041 · DOI 10.1186/s13722-025-00605-7

Verify or expand the search:

Other trials of Care Navigation

Trials testing the same drug.

NCT06317987 — Addressing Barriers to Care for Substance Use Disorder Pilot Study · NA · active not recruiting

Other recruiting trials for Drug Use Disorders

Currently open trials in the same condition.

NCT06163651 — Evaluating a One-Year Version of the Parent-Child Assistance Program · NA · recruiting
NCT06317987 — Addressing Barriers to Care for Substance Use Disorder Pilot Study · NA · active not recruiting
NCT05534568 — The Oklahoma Parent-Child Assistance Program · NA · recruiting
NCT03713983 — Treatment Outcomes Among Patients With Prescription Narcotic Drug Use Disorder · active not recruiting

Other Kaiser Permanente trials

Trials by the same sponsor.

NCT07522645 — Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Dis · NA · not yet recruiting
NCT07474038 — AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment · NA · enrolling by invitation
NCT07467668 — Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure · NA · not yet recruiting
NCT07216859 — Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) · NA · not yet recruiting
NCT07264062 — MetSense Pilot and Feasibility · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06729957 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kaiser Permanente
Last refreshed: 27 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06729957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing